Bristol-Myers Squibb reiterates intent to buy remaining ImClone shares
LAWRENCE TOWNSHIP, N.J. Bristol-Myers Squibb isn’t giving up on its bid to acquire ImClone just yet.
Bristol-Myers Squibb, which already owns 17 percent of ImClone, offered $60 a share to acquire the rest of the company, but ImClone turned it down after receiving a $70 per share offer from an unnamed company.
The company said it hopes to engage directly with ImClone. “We were disappointed to learn yesterday, nearly six weeks after we announced our offer, that ImClone’s special committee unilaterally rejected our offer without discussing its merits with us and our advisors,” Bristol-Myers Squibb wrote in a letter to ImClone.
UI sues Amgen over patent infringement
IOWA CITY, Iowa A major biotech company has trouble with the University of Iowa.
The university is suing Amgen, alleging that it has knowingly infringed on its patents for several years, specifically in its manufacture of drugs such as the rheumatoid arthritis and psoriasis treatment Enbrel (etanercept).
The university is demanding unspecified damages from the Thousand Oaks, Calif., company.
Take Care adds four new vaccines to its program
CONSHOHOCKEN, Pa. Take Care Health Systems, which is owned by Walgreens, has expanded its vaccine program with four new vaccines.
The new vaccination suite includes varicella (chickenpox); measles, mumps and rubella (MMR); pneumococcal (PPV); and human pappilomavirus (HPV).
These vaccinations—in addition to hepatitis B, menactra (meningitis), shingles, tetanus, diphtheria, pertussis (Tdap) and tetanus booster (Td)—are now available at all 223 Take Care clinics within Walgreens.
Flu shots will also be available from Oct. 1 through early 2009.
“Vaccinations are the cornerstone of disease prevention and health promotion,” stated Sandy Ryan, chief nurse practitioner officer at Take Care Health Systems. “Routine immunizations are critical for both children and adults. Adults should ensure they are up to date on recommended vaccines to prevent against common, yet serious, diseases.”